Seasonal Administration of Omalizumab in Patients With Uncontrolled Asthma and Sensitization to Olive Pollen.

Serrano, P; Navas, A; Ruiz-León, B; Herrero, L; Rondón, C; Jurado, A; Moreno-Aguilar, C

Serrano, P; Navas, A; Ruiz-León, B; Herrero, L; Rondón, C; Jurado, A; Moreno-Aguilar, C.

Afiliação

Serrano P; Department of Immunology and Allergy, Reina Sofia University Hospital, Córdoba, Spain.
Navas A; Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/ Reina Sofia University Hospital/University of Córdoba, Córdoba, Spain.
Ruiz-León B; National Network ARADyAL, Carlos III Health Institute, Madrid, Spain.
Herrero L; Department of Immunology and Allergy, Reina Sofia University Hospital, Córdoba, Spain.
Rondón C; Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/ Reina Sofia University Hospital/University of Córdoba, Córdoba, Spain.
Jurado A; National Network ARADyAL, Carlos III Health Institute, Madrid, Spain.
Moreno-Aguilar C; Department of Immunology and Allergy, Reina Sofia University Hospital, Córdoba, Spain.

J Investig Allergol Clin Immunol ; 31(5): 436-438, 2021 Oct 25.

Article em En | MEDLINE | ID: mdl-33237024

Assuntos

Asma; Olea; Asma/tratamento farmacológico; Humanos; Omalizumab/uso terapêutico; Pólen; Estações do Ano

Palavras-chave

Asthma; Olive pollen; Omalizumab; Seasonal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Olea Limite: Humans Idioma: En Revista: J Investig Allergol Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google